Default company panoramic image

Gradient Biomodeling LLC

Gradient quantum similarity approach integrates fundamental knowledge from physics, chemistry and biology and translates it into meaningful drug leads.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Park City, UT, USA
  • Currency USD
  • Employees 2
  • Website

Company Summary

Biomolecular interactions are quantum in nature. Gradient has developed and validated a computational platform for their theoretical modeling. The methodology is based on quantum representation of chemical structures and machine-learning fuzzy-decision algorithms, and takes advantage of the latest bioassay and biomedical big data developments. The technology has been successfully applied against a wide range of therapeutic targets.


  • Default avatar
    Martin N Martinov
    Chief Technology Officer

    Dr. Martinov has implemented extensive IT solutions in pharmaceuticals, diagnostics, and imaging. He holds an MS in Biotechnology from University of Sofia, a PhD in Molecular Biophysics from Florida State, and has done post-doctoral research at Rensselaer Polytechnic Institute.

  • Default avatar
    Nick Kaludov
    Scientific Operations

    Dr. Kaludov is an experienced executive with extensive R&D expertise and a successful industry track record. As an industry executive has transformed two biotechnology research platforms into product pipelines, taken a product through pre-clinical development, founded one biotechnology company, and established several corporate alliances resulting in new IP and increased revenues.

  • Default avatar
    Antoan Goshev
    Vice President, IT

    Mr. Goshev is an IT professional with extensive experience in development of Computer Graphics and Scientific Calculations software; IT operations and IT outsourcing. He holds B.Sc. in Mathematics and M.Sc. in Computer Science from University of Sofia.